Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
bcrx
/
BioCryst Pharmaceuticals Inc
BCRX
Add to Watchlist
8.980
USD
-0.260
-2.81%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
2.28B
Market Cap
Loss
P/E TTM
BioCryst Pharmaceuticals Inc
8.980
-0.260
-2.81%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
6.67%
RA Capital Management, LP
6.23%
Deerfield Management Company, L.P.
5.64%
State Street Investment Management (US)
4.80%
Vanguard Portfolio Management, LLC
4.42%
Other
72.24%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
6.67%
RA Capital Management, LP
6.23%
Deerfield Management Company, L.P.
5.64%
State Street Investment Management (US)
4.80%
Vanguard Portfolio Management, LLC
4.42%
Other
72.24%
Shareholder Types
Shareholders
Proportion
Investment Advisor
32.51%
Investment Advisor/Hedge Fund
25.27%
Hedge Fund
21.44%
Venture Capital
6.23%
Research Firm
3.55%
Private Equity
3.44%
Individual Investor
1.15%
Pension Fund
0.60%
Bank and Trust
0.35%
Other
5.46%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
608
235.68M
92.73%
+6.57M
2025Q4
564
213.88M
103.62%
+15.67M
2025Q3
578
198.21M
105.86%
-3.39M
2025Q2
567
200.28M
97.51%
+20.52M
2025Q1
541
179.39M
95.89%
-21.22M
2024Q4
539
169.89M
99.17%
-5.66M
2024Q3
532
176.74M
101.53%
-3.05M
2024Q2
510
179.40M
103.13%
-5.65M
2024Q1
522
185.07M
103.37%
-28.22M
2023Q4
527
182.31M
101.91%
+1.15M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
16.94M
6.75%
+25.99K
+0.15%
Dec 31, 2025
RA Capital Management, LP
15.83M
6.31%
+525.00K
+3.43%
Dec 31, 2025
Deerfield Management Company, L.P.
14.34M
5.72%
+2.17M
+17.85%
Dec 31, 2025
State Street Investment Management (US)
11.07M
4.42%
+1.27M
+12.91%
Dec 31, 2025
Kynam Capital Management LP
9.37M
3.73%
-23.74K
-0.25%
Dec 31, 2025
Two Sigma Investments, LP
8.60M
3.43%
-55.91K
-0.65%
Dec 31, 2025
Janus Henderson Investors
7.40M
2.95%
+7.31M
+7807.21%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.05M
2.02%
+1.48K
+0.03%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Genomics Immunology and Healthcare ETF
2.49%
Invesco Biotechnology & Genome ETF
2.26%
Virtus LifeSci Biotech Products ETF
1.13%
State Street SPDR S&P Biotech ETF
0.66%
ALPS Medical Breakthroughs ETF
0.64%
Invesco NASDAQ Future Gen 200 ETF
0.47%
Direxion Daily S&P Biotech Bull 3X Shares
0.41%
First Trust Small Cap Growth AlphaDEX Fund
0.26%
Principal U.S. Small-Cap ETF
0.23%
Inspire Small/Mid Cap ESG ETF
0.2%
View more
iShares Genomics Immunology and Healthcare ETF
Proportion
2.49%
Invesco Biotechnology & Genome ETF
Proportion
2.26%
Virtus LifeSci Biotech Products ETF
Proportion
1.13%
State Street SPDR S&P Biotech ETF
Proportion
0.66%
ALPS Medical Breakthroughs ETF
Proportion
0.64%
Invesco NASDAQ Future Gen 200 ETF
Proportion
0.47%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.41%
First Trust Small Cap Growth AlphaDEX Fund
Proportion
0.26%
Principal U.S. Small-Cap ETF
Proportion
0.23%
Inspire Small/Mid Cap ESG ETF
Proportion
0.2%